Additionally, a recent meta-analysis of 18 trials assessing spironolactone effects on fasting glucose and insulin, hemoglobin A1c, and homeostatic model assessment (HOMA)-insulin resistance (IR) showed that spironolactone increased HbA1c but had no clear effect on fasting glucose, HOMA-IR, and insulin levels [249]. Here, INS is linked to Insulin resistance.